Volume 4, Issue 2 (6-2013)                   jdc 2013, 4(2): 69-75 | Back to browse issues page

XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Handjani, MD F, Sadati, MD M S, Firoozabadi, MD A, Rezaei V, Akramzadeh S. Relationship between systemic isotretinoin and induction of depression in acne vulgaris patients. jdc 2013; 4 (2) :69-75
URL: http://jdc.tums.ac.ir/article-1-5031-en.html
1- , msadati63@yahoo.com
Abstract:   (9029 Views)
Background and Aim: Acne is one of the most common skin diseases. One of the best treatments is systemic isotretinoin. Some studies link its use with depression, psychiatric problems and suicide, but it is still a matter of debate. So, this study was designed to determine the frequency of depression in acne patients, treated with isotretinoin.
Methods: Fifty-nine acne patients between 16 -30 years old were included. The patients received 0.5-1 mg/kg/day isotretinoin for 16 weeks. At the beginning and at the end of study, the Beck questionnaire was completed by the patients and the results were analyzed.
Results: The mean score of the Beck questionnaire was 13.19 at the beginning of the study and 14.80 after 4 months of treatment with isotretinoin (P=0.0001).
Conclusion: The results of this study showed that isotretinoin may have a small, but still noticeable increase in depression scores of acne patients. However, it is important to consider that various other parameters, such as individual’s psychological status at the time of completing the questionnaire, might influence the results. So, further studies with more patients and longer durations, and the use of other pertinent questionnaires, are recommended.
Full-Text [PDF 285 kb]   (2838 Downloads)    
Type of Study: Research | Subject: Special
Received: 2013/05/21 | Accepted: 2013/07/26 | Published: 2013/09/21

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 , Tehran University of Medical Sciences, CC BY-NC 4.0

Designed & Developed by : Yektaweb